Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr The Hindu Business Line 6d
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr The Times of India 6d
Lakewood-Amedex Biotherapeutics announces world-renowned expert David g. Armstrong, M.D., pH.D., as study chair for Phase 2a trial of Nu-3 in infected diabetic foot ulcers PR Newswire (Press Release) 2h Biotechnology Stock Market (US) Stock Market
World-first gene therapy to target devastating rare immune disorder NHS Blood and Transplant (Press Release) 4h Biotechnology NHS Biology
STAT Plus: Facing a brutal run, battered vaccine makers still see cause for hope STAT 5h Pharma Science
[BIO USA 2026] Lotte Biologics accelerates Songdo plant toward commercial production, eyes 1st global orders Korea Biomedical Review 11h Construction (World) California Business Biotechnology
How a Drug with more negative than positive studies won FDA approval Medpage Today 20h FDA Global Health Science
Turtlemint Fintech Solutions raises ₹397 crore from anchor investors The Hindu Business Line 7d Insurance (World) All sources
Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr The Hindu Business Line 6d Anthem Biosciences Societe General Insurance (World)
AIA, Prudential create new jobs in Hong Kong for Asian wealth businesses: Bloomberg Hong Kong Standard 08:40 Tue, 16 Jun Insurance (World) Hong Kong China
Turtlemint IPO Day 2: Issue subscribed 48% so far. Check GMP, subscription status, review. Apply or not? Mint 3d Turtlemint IPO Insurance (World) Flotations/IPOs
SanlamAllianz’s Heinie Werth to retire, Hennie Nel succeeds as CEO Reinsurance News 2d Allianz Business UK Insurance
EU to escalate Meta probe into addictive design that hooks kids Insurance Claims Journal 2d Meta Top Tech Brands
Hormuz traffic picks up as more tankers broadcast crossings Insurance Journal 2d Strait of Hormuz Persian Gulf Middle East
